OMS, ONUDD y ONUSIDA: Guía técnica para países. Prevención, tratamiento y atención relacionados con el VIH para usuarios de drogas inyectables – Revisión 2012

Esta versión revisada ofrece a los países orientación técnica sobre medidas de seguimiento para prevenir y tratar la infección por VIH entre personas que se inyectan drogas.

Más información, en inglés, disponible abajo.

Suscríbase a las Alertas mensuales del IDPC para recibir información sobre cuestiones relacionadas con políticas sobre drogas.

This is a revision of the 2009 Technical Guide, which provides technical guidance to countries on monitoring efforts to prevent and treat HIV infection among people who inject drugs (PWID) and for setting ambitious but achievable national targets for scaling up towards universal access.

This tool has been developed collaboratively by three United Nations (UN) agencies—the World Health Organization (WHO), the United Nations Office on Drugs and Crime (UNODC) and the Joint United Nations Programme on HIV/AIDS (UNAIDS)—and through a process of consultation with international experts in the field.

This document provides countries with:

• a comprehensive package of interventions for the prevention, treatment and care of HIV infection among people who inject drugs, which has not changed from the 2009 version of this guidance;
• a set of indicators to monitor and evaluate the implementation and impact of these interventions;
• advice on setting targets for scale-up, to maximize the impact of HIV prevention and care among people who inject drugs;
• examples of data sources and useful tools to assist with programme development, implementation, monitoring and evaluation.

This Technical Guide is intended to assist government agencies, non-government organizations (NGOs), communities and service providers involved in developing, implementing, monitoring and evaluating HIV prevention, treatment and care programmes for people who inject drugs (PWID). The framework proposed can be applied at regional, national, sub-national and service-delivery levels.

Keep up-to-date with drug policy developments by subscribing to the IDPC Monthly Alert.